Mutations in human glypican genes are closely associated with growth anomalies such as Simpson-Golabi-Behmel Syndrome (SGBS, overgrowth) or omodysplasia (bone undergrowth) (Pilia et al., 1996; Campos-Xavier et al., 2009). This evidence concerns the gene GPC1 and Simpson-Golabi-Behmel syndrome.